Denifanstat (TVB-2640)

Catalog No.S9714 Batch:S971401

Technical Data

Formula	C₂₇H₂₉N₅O
Molecular Weight	439.55	CAS No.	1399177-37-7
Solubility (25°C)*	In vitro	DMSO	88 mg/mL (200.2 mM)
		Ethanol	88 mg/mL (200.2 mM)
		Water	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. * Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description

Denifanstat (TVB-2640) is an orally bioavailable, pharmacological fatty acid synthase (FAS/FASN) inhibitor with therapeutic potential in patients with NAFLD and nonalcoholic steatohepatitis.

Targets

FAS ^[1]

In vitro

TVB-2640 markedly inhibits SARS-CoV-2 with EC50s of 4 nM. TVB-2640 could strikingly inhibit SARS-CoV-2 new variants with similar inhibitory effects on the early-lineage SARS-CoV-2 (USA-WA1/2020) virus.^[2]

In vivo

TVB-2640 shows significant in vivo antiviral activity and protects SARS-CoV-2-infected mice for survival.^[2]

Protocol (from reference)

Cell Assay:^{^[2]}	Cell lines HEK293T-hACE2, Caco-2, MEF-hACE2 cells Concentrations 100 nM for HEK293T-hACE2 cells; 2 µM for NCI-H1355, NCI-1437 and Caco-2 cells; 1 µM for MEF-hACE2 cells Incubation Time 16+24 h Method Indicated cells were pre-treated with TVB-2640 from 16 h before infection and then infected with SARS-CoV-2-mNG. Fluorescence images were acquired at 48 hpi. Hoechst 33342 was used for nuclear staining. Assessment of anti-SARS-CoV-2 ability of FAS inhibitors in multiple cell lines. Indicated cells were pre-treated with TVB-2640 and infected with SARS-CoV-2 for 24 h, after infection cells were collected for quantification of intracellular viral RNA by qPCR. (Data sourced from selleck products)
Animal Study:^{^[2]}	Animal Models K18-hACE2 transgenic mice infected by SARS-CoV-2 Dosages 8 mg kg-1 body weight Administration i.p. (Data sourced from selleck products)

Cell Assay:^{^[2]}

Cell lines
HEK293T-hACE2, Caco-2, MEF-hACE2 cells
Concentrations
100 nM for HEK293T-hACE2 cells; 2 µM for NCI-H1355, NCI-1437 and Caco-2 cells; 1 µM for MEF-hACE2 cells
Incubation Time
16+24 h
Method
Indicated cells were pre-treated with TVB-2640 from 16 h before infection and then infected with SARS-CoV-2-mNG. Fluorescence images were acquired at 48 hpi. Hoechst 33342 was used for nuclear staining. Assessment of anti-SARS-CoV-2 ability of FAS inhibitors in multiple cell lines. Indicated cells were pre-treated with TVB-2640 and infected with SARS-CoV-2 for 24 h, after infection cells were collected for quantification of intracellular viral RNA by qPCR.

(Data sourced from selleck products)

Animal Study:^{^[2]}

Animal Models
K18-hACE2 transgenic mice infected by SARS-CoV-2
Dosages
8 mg kg-1 body weight
Administration
i.p.

(Data sourced from selleck products)

References

Selleck's Denifanstat (TVB-2640) has been cited by 7 publications

Formate promotes invasion and metastasis in reliance on lipid metabolism [ Cell Rep, 2023, 42(9):113034]	PubMed: 37651228
FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma [ J Transl Med, 2023, 21(1):32]	PubMed: 36650542
Imaging the metabolic reprograming of fatty acid synthesis pathway enables new diagnostic and therapeutic opportunity for breast cancer [ Cancer Cell Int, 2023, 23(1):83]	PubMed: 37120513
The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer [ Front Oncol, 2022, 12:899987]	PubMed: 35898882
Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication [ Nat Metab, 2021, 10.1038/s42255-021-00479-4]	PubMed: 34580494
Metabolic convergence on lipogenesis in RAS, BCR-ABL, and MYC-driven lymphoid malignancies [ Cancer Metab, 2021, 9(1):31]	PubMed: 34399819
Molecular Response to PARP1 Inhibition in Ovarian Cancer Cells as Determined by Mass Spectrometry Based Proteomics [ bioRxiv, 2021, 10.1101/2021.03.12.435005]	PubMed: None

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.